# FDA 483 - Hikma Injectables USA Inc - June 25, 2024

Source: https://www.keypedia.com/records/483/hikma-injectables-usa-inc/eebc6c03-e0e6-4023-aab0-b200847ab652

> FDA 483 for Hikma Injectables USA Inc on June 25, 2024. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Hikma Injectables USA Inc
- Inspection Date: 2024-06-25
- Product Type: Drugs
- Office Name: New Jersey District Office
- Summary: The FDA Form 483 details observations from an inspection of a facility manufacturing sterile drug products, including Phenylephrine HCL 1 mg per 10 ml (100 mcg/ml) in 0.9% Sodium Chloride Injection.

Several deficiencies were noted in aseptic processing areas. The design of syringe filling lines and enclosures fails to maintain first-pass HEPA-filtered laminar airflow over critical areas, such as open syringes and tamper-evident caps within ISO 5 classified filling enclosures. Airflow visualization studies revealed objectionable patterns, including turbulence and upward circulating air, which firm management accepted without corrective actions. Additionally, a divider/safety guard obstructs first-pass HEPA-filtered air over critical components.

Environmental monitoring is deficient as active air sampling for airborne viable monitoring is not performed in the ISO 5 classified syringe filling and capping zone during sterile filling operations.

Compounding finished drug product samples for quality control testing are not representative of each sub-assembly when a sub-assembly batch process is followed, contrary to SOPDTN15106. For example, for Phenylephrine HCL 1 mg per 10 ml (100 mcg/ml) in 0.9% Sodium Chloride Injection Lot #, there was no record demonstrating that samples tested were representative of each sub-assembly.

Finally, laboratory controls are inadequate. The firm does not fully follow SOPDTN15087, Growth Promotion Test, to

## Related Documents

- [483 - 2022-06-08](https://www.keypedia.com/records/483/hikma-injectables-usa-inc/59b87e50-d5f5-426b-bd53-dc444613e108)
- [483 - 2025-08-08](https://www.keypedia.com/records/483/hikma-injectables-usa-inc/eca9c36e-3c8f-4aa1-b5da-39c3f9544970)

Company: https://www.keypedia.com/companies/hikma-injectables-usa-inc/9d594ef4-e334-4c2d-a6ed-90845b8c29df

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248